Ignite Creation Date:
2024-05-06 @ 11:06 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03433183
Status:
COMPLETED
Last Update Posted:
2023-12-26
First Post:
2018-01-29
Brief Title:
SARC031 MEK Inhibitor Selumetinib AZD6244 in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
Sponsor:
Sarcoma Alliance for Research through Collaboration
Organization:
Sarcoma Alliance for Research through Collaboration
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-29
First Submit QC Date:
February 7 2018
Study First Post Date:
2018-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-22
Last Update Post Date:
2023-12-26
Last Update Post Date Type:
ACTUAL